Medical device maker Becton Dickinson and Co said on Thursday it expects as much as $1.5 billion in sales from its COVID-19 diagnostic test next year, after reporting a quarterly profit that beat Wall Street estimates.
(This September 30 story corrects paragraph 4 to say probe is only on Covidien-Newport deal)
U.S. states are seeking a combined $26.4 billion from three major drug distributors and Johnson & Johnson to settle opioid litigation against the companies, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.
Medical device maker Boston Scientific Corp on Wednesday posted a surprise adjusted quarterly profit and said demand for elective procedures picked up pace in July following an easing of coronavirus-driven restrictions.
Walgreens Boots Alliance Inc said on Monday its biggest shareholder, Stefano Pessina, will step down as the chief executive officer after five years at the helm, during which the pharmacy group's value more than halved.
Biogen Inc raised its 2020 earnings forecast on Wednesday after better-than-expected sales of its multiple sclerosis treatment Tecfidera helped the drugmaker beat second-quarter profit estimates.
Abbott Laboratories said on Thursday demand for its coronavirus tests will likely remain high even after a safe and effective vaccine is available as the medical device maker forecast full-year profit above analysts' estimates.
July 15 The U.S. government will buy Becton,
Dickinson and Co's COVID-19 testing devices and kits,
the company said on Wednesday, as it ramps up its testing for
the virus that has been spreading at an alarming rate.
Walgreens Boots Alliance Inc said on Thursday it would close stores, cut jobs and suspend share repurchase as the coronavirus crisis hammered its ailing Boots UK division, leading to a $2 billion impairment charge in the third quarter. | Video